Lifecore Biomedical Inc Sample Contracts

EXHIBIT 10.1 LETTER AMENDMENT NO. 2
Revolving Credit Agreement • February 9th, 2005 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances)
AutoNDA by SimpleDocs
PURCHASE AGREEMENT
Purchase Agreement • October 10th, 1995 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota
CREDIT AGREEMENT
Credit Agreement • January 28th, 1998 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota
AMENDMENT NO. 5 TO CREDIT AND SECURITY AGREEMENT
Credit and Security Agreement • November 12th, 2002 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota
RECITALS
Security Agreement • January 28th, 1998 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota
FIRST AMENDMENT TO CREDIT AGREEMENT
Credit Agreement • August 27th, 1998 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances)
AGREEMENT AND PLAN OF MERGER by and among SBT HOLDINGS INC., SBT ACQUISITION INC. and LIFECORE BIOMEDICAL, INC. Dated as of January 15, 2008
Merger Agreement • January 15th, 2008 • Lifecore Biomedical Inc • Surgical & medical instruments & apparatus • Delaware

THIS AGREEMENT AND PLAN OF MERGER (hereinafter referred to as this “Agreement”) is entered into as of January 15, 2008, by and among SBT Holdings Inc. (“Parent”), a Delaware corporation, SBT Acquisition Inc. (“Purchaser”), a Minnesota corporation and direct wholly-owned subsidiary of Parent, and Lifecore Biomedical, Inc., a Minnesota corporation (the “Company”).

NONCOMPETITION AND NONSOLICITATION AGREEMENT
Noncompetition and Nonsolicitation Agreement • September 13th, 2006 • Lifecore Biomedical Inc • Surgical & medical instruments & apparatus • Minnesota

This Noncompetition and Nonsolicitation Agreement (“Agreement”) is made effective as of January 3, 2006, by and between Ben Beckham (“Executive”), an individual resident of the State of Texas, and Lifecore Biomedical, Inc., (“Lifecore”), a corporation organized under the laws of the State of Minnesota.

5,630,000 City of Chaska, Minnesota Variable Rate Demand Purchase Revenue Bonds (Lifecore Biomedical, Inc. Project), Series 2004 TAX EXEMPTION AGREEMENT Dated as of August 1, 2004 By and Between CITY OF CHASKA, MINNESOTA and WELLS FARGO BANK, NATIONAL...
Tax Exemption Agreement • September 13th, 2004 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota

still be required to be rebated. In some cases, the payment of rebate may assist in compliance with the yield restriction requirements. Thus, rebate compliance and yield restriction may, in certain circumstances, operate together rather than independently. In any case, rebate compliance is essential to the maintenance of the tax exemption of interest on the Bonds even if no amounts are subject to yield restriction. Terms not defined herein shall have the meanings set forth in the Tax Agreement. Yield is defined in Article VII of the Tax Agreement.

SECURITY AGREEMENT
Security Agreement • September 13th, 2004 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances)

THIS SECURITY AGREEMENT (this “Agreement”) is made as of this 1st day of August, 2004, by LIFECORE BIOMEDICAL, INC., a Minnesota corporation (the “Debtor”), in favor of M&I MARSHALL & ILSLEY BANK, a Wisconsin state banking corporation (the “Secured Party”).

5,630,000 CITY OF CHASKA, MINNESOTA VARIABLE RATE DEMAND PURCHASE REVENUE BONDS (LIFECORE BIOMEDICAL, INC. PROJECT), SERIES 2004 BOND PURCHASE AGREEMENT August 19, 2004 Between CITY OF CHASKA, MINNESOTA, LIFECORE BIOMEDICAL, INC. and NORTHLAND...
Bond Purchase Agreement • September 13th, 2004 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota

We (sometimes referred to as the “Underwriter”) hereby offer to purchase, upon the terms and conditions hereinafter specified, $5,630,000 aggregate principal amount of Variable Rate Demand Purchase Revenue Bonds (Lifecore Biomedical, Inc. Project), Series 2004 (the “Bonds”), to be issued by City of Chaska, Minnesota (referred to as the “City” or the “Issuer”). The Bonds are described in the Official Statement prepared in connection with the issuance of the Bonds (together with the respective Appendices thereto, the “Official Statement”). If and when accepted by all of you, this document shall constitute our Bond Purchase Agreement.

LIMITED GUARANTEE
Limited Guarantee • January 15th, 2008 • Lifecore Biomedical Inc • Surgical & medical instruments & apparatus • Delaware

LIMITED GUARANTEE, dated as of January 15, 2008 (this “Limited Guarantee”), by Warburg Pincus Private Equity IX, L.P. (the “Guarantor”) in favor of Lifecore Biomedical, Inc., a Minnesota corporation (the “Guaranteed Party”). Each capitalized term used and not defined herein shall have the meaning ascribed to it in the Merger Agreement, except as otherwise provided.

LIFECORE BIOMEDICAL, INC. FORM OF RESTRICTED STOCK AWARD AGREEMENT
Restricted Stock Award Agreement • November 1st, 2004 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota
LIFECORE BIOMEDICAL, INC. INCENTIVE STOCK OPTION AGREEMENT
Incentive Stock Option Agreement • September 13th, 2007 • Lifecore Biomedical Inc • Surgical & medical instruments & apparatus

THIS OPTION AGREEMENT is made as of the _____ of ______, 20_____ between Lifecore Biomedical, Inc., a Minnesota corporation (hereinafter called the “Company”), and ____________ an employee of the Company or one or more of its subsidiaries (hereinafter called the “Optionee”).

REIMBURSEMENT AGREEMENT BY AND BETWEEN LIFECORE BIOMEDICAL, INC. AND M&I MARSHALL & ILSLEY BANK IN CONNECTION WITH $5,699,411.00 LETTER OF CREDIT Dated As Of: August 1, 2004
Reimbursement Agreement • September 13th, 2004 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota

THIS REIMBURSEMENT AGREEMENT, made as of the 1st day of August, 2004, by and between LIFECORE BIOMEDICAL, INC., a Minnesota corporation (the “Borrower”), and M&I MARSHALL & ILSLEY BANK, a Wisconsin state banking corporation with its banking house located in Milwaukee, Wisconsin (the “Lender”).

MORTGAGE, SECURITY AGREEMENT, ASSIGNMENT OF LEASES AND RENTS AND FIXTURE FINANCING STATEMENT
Mortgage, Security Agreement, Assignment of Leases and Rents, and Fixture Financing Statement • September 13th, 2004 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota

THIS MORTGAGE, SECURITY AGREEMENT, ASSIGNMENT OF LEASES AND RENTS AND FIXTURE FINANCING STATEMENT (this “Mortgage”) is made as of the 1st day of August, 2004, by LIFECORE BIOMEDICAL, INC., a Minnesota corporation (“Borrower”), having its principal office at 3515 Lyman Boulevard, Chaska, Minnesota 55318, in favor of M&I MARSHALL & ILSLEY BANK, a Wisconsin state banking corporation (“Lender”), having its principal office at 651 Nicollet Mall, Minneapolis, Minnesota 55402, Attention: Scott D. Thorson, or its assignee.

AutoNDA by SimpleDocs
PLEDGE AND SECURITY AGREEMENT
Pledge and Security Agreement • September 13th, 2004 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota

THIS PLEDGE AND SECURITY AGREEMENT is made as of the 1st day of August, 2004, among LIFECORE BIOMEDICAL, INC., a Minnesota corporation (the “Pledgor”), M&I MARSHALL & ILSLEY BANK, a Wisconsin state banking corporation (the “Lender”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Agent”).

INDEMNIFICATION AGREEMENT (OFFICER)
Indemnification Agreement • November 19th, 2007 • Lifecore Biomedical Inc • Surgical & medical instruments & apparatus • Minnesota

THIS AGREEMENT is made and entered into as of this ___day of November, 2007, by and between Lifecore Biomedical, Inc., a Minnesota corporation (the “Company”), and (“Indemnitee”).

5,630,000 City of Chaska, Minnesota Variable Rate Demand Purchase Revenue Bonds (Lifecore Biomedical, Inc. Project) Series 2004 REMARKETING AGREEMENT Dated as of August 1, 2004 Between LIFECORE BIOMEDICAL, INC. and NORTHLAND SECURITIES, INC. This...
Remarketing Agreement • September 13th, 2004 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota

This REMARKETING AGREEMENT dated as of August 1, 2004, between LIFECORE BIOMEDICAL, INC., a Minnesota corporation (the “Borrower”) and NORTHLAND SECURITIES, INC., acting as remarketing agent (the “Remarketing Agent”);

AMENDMENT TO MANUFACTURING AGREEMENT
Manufacturing Agreement • February 11th, 2008 • Lifecore Biomedical Inc • Surgical & medical instruments & apparatus

The Manufacturing Agreement between Alcon Pharmaceuticals Ltd. (“Alcon”) and Lifecore Biomedical, Inc. dated effective on January 1, 2006, is hereby amended as follows:

MANUFACTURING AGREEMENT
Manufacturing Agreement • February 11th, 2008 • Lifecore Biomedical Inc • Surgical & medical instruments & apparatus • Delaware

THIS MANUFACTURING AGREEMENT (the “Agreement”), effective as of the 1st day of January, 2006, (the “Effective Date”), is by and between ALCON PHARMACEUTICALS LTD., a Swiss corporation with its principal offices at Bösch 69, P.O. Box 62, 6331 Hünenberg, Switzerland (hereinafter referred to as “ALCON”) and LIFECORE BIOMEDICAL, INC., a Minnesota corporation with its principal offices at 3515 Lyman Blvd., Chaska, MN 55318 (hereinafter referred to as “SELLER”).

AMENDMENT NO. 2 TO CREDIT AND SECURITY AGREEMENT
Credit and Security Agreement • September 15th, 2000 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota

This AMENDMENT No. 1 TO CREDIT AND SECURITY AGREEMENT, dated as of July 21, 2000 (the "Amendment"), between Lifecore Biomedical, Inc. (the "Borrower") and U.S. Bank National Association (the "Lender").

AMENDMENT NO. 1 TO CREDIT AND SECURITY AGREEMENT AND CONSENT
Credit and Security Agreement • September 15th, 2000 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota

This AMENDMENT No. 1 TO CREDIT AND SECURITY AGREEMENT AND CONSENT, dated as of February 7, 2000 (the "Amendment"), between Lifecore Biomedical, Inc. (the "Borrower") and U.S. Bank National Association (the "Lender").

LIFECORE BIOMEDICAL, INC. NON-QUALIFIED STOCK OPTION AGREEMENT (FOR DIRECTORS) AMENDMENT NO. 1
Non-Qualified Stock Option Agreement • November 22nd, 2006 • Lifecore Biomedical Inc • Surgical & medical instruments & apparatus

THIS AMENDMENT NO. 1 (the “Amendment”) to the OPTION AGREEMENT (the “Agreement”) dated as of June 15, 2006 between the parties hereto, is made as of November 20, 2006 between LIFECORE BIOMEDICAL, INC., a Minnesota corporation (the “Company”), and Martin J. Emerson, a director of the Company (the “Optionee”).

SEPARATION AGREEMENT
Separation Agreement • September 13th, 2005 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances)
RECITALS
Pledge Agreement and Security Agreement • January 28th, 1998 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances)
LETTER AMENDMENT NO. 3
Revolving Credit Agreement • December 22nd, 2006 • Lifecore Biomedical Inc • Surgical & medical instruments & apparatus

We refer to the Revolving Credit Agreement dated as of December 18, 2002, as amended (the “Credit Agreement”) between you and us. Unless otherwise defined in this letter amendment, terms defined in the Credit Agreement are used in this letter amendment as defined in the Credit Agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!